In a report released today, Juan C. Sanabria from BMO Capital reiterated a Buy rating on Healthpeak Properties (DOC – Research Report), with a ...
BMO Capital analyst John McNulty lowered the firm’s price target on Chemours (CC) to $27 from $34 and keeps an Outperform rating on the shares ...
BMO Capital analyst Jeffrey Silber lowered the firm’s price target on Clean Harbors (CLH) to $270 from $284 due to a reduction in the firm’s ...
1d
Stocktwits on MSNMoody’s Stock In Spotlight After UBS, BMO Capital Raise Price Targets Following Upbeat Q4: Retail Stays Extremely BullishShares of Moody's Corp (MCO) were in the spotlight on Tuesday after two brokerages raised their price targets on the stock ...
BMO Capital raised the firm’s price target on DTE Energy (DTE) to $135 from $125 and keeps a Market Perform rating on the ...
Investors have no practical way to evaluate the effectiveness of initiatives from the Elon Musk-led entity known as the Department of Government Efficiency, and it’s hard to see any clarity for the ...
BMO Capital lowered the firm’s price target on Harley-Davidson (HOG) to $35 from $40 and keeps an Outperform rating on the ...
Focus on 42 stocks with solid dividend growth as inflation runs rampant Belski and his colleagues at BMO Capital Markets have nine investing strategy portfolios that can serve as models for investors.
Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by BMO Capital Markets from $156.00 to $139.00 in a report ...
Albemarle (NYSE:ALB – Free Report) had its target price reduced by BMO Capital Markets from $150.00 to $140.00 in a research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results